Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Fresh Day Meds vs Mochi Health

Two GLP-1 desks, one scoreboard. We put Fresh Day Meds and Mochi Health head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 47 · Grade B−

Fresh Day Meds

Visit Fresh Day Meds Full brief →
vs
Higher Brief ScoreNo. 41 · Grade B−

Mochi Health

Visit Mochi Health Full brief →

The verdict

Mochi Health takes this head-to-head.

Mochi Health scores 81 to 80 on our six-factor Brief Score — A recognizable coaching-forward brand, but availability is capped at roughly 15 states.

That doesn't make Fresh Day Meds a bad call — it's best for readers who want lowest-cost compounded glp-1 from a legitscript-certified texas platform. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
66
83
Supply Reliability
83
83
Transparency
88
82
Access Breadth
90
78
Clinical Oversight
78
80
Track Record
82
82
Fresh Day MedsBrief Score 80 · 81Mochi Health

Price, coverage & the tracker

Fresh Day MedsMochi Health
Brief Score80/100 (B−)81/100 (B−)
SemaglutideFrom $140/mo (all doses, compounded)$138/mo
TirzepatideFrom $179/mo (all doses, compounded)$238/mo
CoverageAll 50 states15 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerNewnew to the tracker, no prior readingStableprice stable

Fresh Day Meds: New to the tracker on 1 August 2026. The published line reads From $140/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Mochi Health: $138 sema / $238 tirz; footprint capped near 15 states.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.